|
Gabapentin 300 mg/1 CAPSULE
Bryant · NDC 72162-1533-01 · 100 CAPSULE in 1 BOTTLE, PLASTIC (72162-1533-1) |
72162-1533-01 |
— |
FDA-listed |
View → |
|
Gabapentin 400 mg/1 CAPSULE
Bryant · NDC 72162-1534-01 · 100 CAPSULE in 1 BOTTLE, PLASTIC (72162-1534-1) |
72162-1534-01 |
— |
FDA-listed |
View → |
|
Gabapentin 300 mg/1 CAPSULE
Bryant · NDC 72162-1533-01 · 100 CAPSULE in 1 BOTTLE, PLASTIC (72162-1533-1) |
72162-1533-01 |
— |
FDA-listed |
View → |
|
Gabapentin 400 mg/1 CAPSULE
Bryant · NDC 72162-1534-01 · 100 CAPSULE in 1 BOTTLE, PLASTIC (72162-1534-1) |
72162-1534-01 |
— |
FDA-listed |
View → |
|
Gabapentin 100 mg/1 CAPSULE
Bryant · NDC 72162-1532-01 · 100 CAPSULE in 1 BOTTLE, PLASTIC (72162-1532-1) |
72162-1532-01 |
— |
FDA-listed |
View → |
|
Galantamine 8 mg/1 TABLET, FILM COATED
Bryant · NDC 72162-2566-06 · 60 TABLET, FILM COATED in 1 BOTTLE (72162-2566-6) |
72162-2566-06 |
— |
FDA-listed |
View → |
|
Galantamine Hydrobromide 24 mg/1 CAPSULE, EXTENDED RELEASE
Bryant · NDC 72162-1448-03 · 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72162-1448-3) |
72162-1448-03 |
— |
FDA-listed |
View → |
|
Galantamine Hydrobromide 16 mg/1 CAPSULE, EXTENDED RELEASE
Bryant · NDC 72162-1447-03 · 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72162-1447-3) |
72162-1447-03 |
— |
FDA-listed |
View → |
|
Galantamine Hydrobromide 8 mg/1 CAPSULE, EXTENDED RELEASE
Bryant · NDC 72162-1446-03 · 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72162-1446-3) |
72162-1446-03 |
— |
FDA-listed |
View → |
|
GEMFIBROZIL 600 mg/1 TABLET
Bryant · NDC 72162-2119-06 · 60 TABLET in 1 BOTTLE (72162-2119-6) |
72162-2119-06 |
— |
FDA-listed |
View → |
|
Glipizide 10 mg/1 TABLET
Bryant · NDC 72162-2102-00 · 1000 TABLET in 1 BOTTLE (72162-2102-0) |
72162-2102-00 |
— |
FDA-listed |
View → |
|
Glipizide 10 mg/1 TABLET
Bryant · NDC 72162-2215-00 · 1000 TABLET in 1 BOTTLE (72162-2215-0) |
72162-2215-00 |
— |
FDA-listed |
View → |
|
Glipizide 10 mg/1 TABLET, EXTENDED RELEASE
Bryant · NDC 72162-2614-01 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2614-1) |
72162-2614-01 |
— |
FDA-listed |
View → |
|
Glipizide 5 mg/1 TABLET
Bryant · NDC 72162-2103-00 · 1000 TABLET in 1 BOTTLE (72162-2103-0) |
72162-2103-00 |
— |
FDA-listed |
View → |
|
Glipizide 10 mg/1 TABLET
Bryant · NDC 72162-2215-00 · 1000 TABLET in 1 BOTTLE (72162-2215-0) |
72162-2215-00 |
— |
FDA-listed |
View → |
|
GLYCOPYRROLATE 1 mg/1 TABLET
Bryant · NDC 72162-2597-01 · 100 TABLET in 1 BOTTLE (72162-2597-1) |
72162-2597-01 |
— |
FDA-listed |
View → |
|
Glycopyrrolate 1 mg/1 TABLET
Bryant · NDC 72162-1477-01 · 100 TABLET in 1 BOTTLE (72162-1477-1) |
72162-1477-01 |
— |
FDA-listed |
View → |
|
Glycopyrrolate 2 mg/1 TABLET
Bryant · NDC 72162-1478-01 · 100 TABLET in 1 BOTTLE (72162-1478-1) |
72162-1478-01 |
— |
FDA-listed |
View → |
|
GLYCOPYRROLATE 2 mg/1 TABLET
Bryant · NDC 72162-2598-01 · 100 TABLET in 1 BOTTLE (72162-2598-1) |
72162-2598-01 |
— |
FDA-listed |
View → |
|
Glycopyrrolate 1 mg/1 TABLET
Bryant · NDC 72162-1477-01 · 100 TABLET in 1 BOTTLE (72162-1477-1) |
72162-1477-01 |
— |
FDA-listed |
View → |
|
Glycopyrrolate 2 mg/1 TABLET
Bryant · NDC 72162-1478-01 · 100 TABLET in 1 BOTTLE (72162-1478-1) |
72162-1478-01 |
— |
FDA-listed |
View → |
|
Guaifenesin 100 mg/5mL LIQUID
Bryant · NDC 72162-2278-02 · 473 mL in 1 BOTTLE (72162-2278-2) |
72162-2278-02 |
— |
FDA-listed |
View → |
|
Guaifenesin and Dextromethorphan Hydrobromide 10 mg/5mL; 100 mg/5mL SYRUP
Bryant · NDC 72162-2277-02 · 237 mL in 1 BOTTLE (72162-2277-2) |
72162-2277-02 |
— |
FDA-listed |
View → |
|
Guanfacine 2 mg/1 TABLET, EXTENDED RELEASE
Bryant · NDC 72162-1799-01 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-1799-1) |
72162-1799-01 |
— |
FDA-listed |
View → |
|
Guanfacine 1 mg/1 TABLET, EXTENDED RELEASE
Bryant · NDC 72162-1798-01 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-1798-1) |
72162-1798-01 |
— |
FDA-listed |
View → |
|
Guanfacine 4 mg/1 TABLET, EXTENDED RELEASE
Bryant · NDC 72162-1801-01 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-1801-1) |
72162-1801-01 |
— |
FDA-listed |
View → |
|
Guanfacine 2 mg/1 TABLET, EXTENDED RELEASE
Bryant · NDC 72162-1799-01 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-1799-1) |
72162-1799-01 |
— |
FDA-listed |
View → |
|
Guanfacine 4 mg/1 TABLET, EXTENDED RELEASE
Bryant · NDC 72162-1801-01 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-1801-1) |
72162-1801-01 |
— |
FDA-listed |
View → |
|
Halobetasol Propionate .5 mg/g OINTMENT
Bryant · NDC 72162-2258-02 · 1 TUBE in 1 CARTON (72162-2258-2) / 50 g in 1 TUBE |
72162-2258-02 |
— |
FDA-listed |
View → |
|
Halobetasol Propionate .5 mg/g OINTMENT
Bryant · NDC 72162-1396-02 · 1 TUBE in 1 CARTON (72162-1396-2) / 15 g in 1 TUBE |
72162-1396-02 |
— |
FDA-listed |
View → |